Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 1/20 | 0.36 |
| ▸ | ICMT | O60725 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 2/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20313802 | 0.94 | KDM4E (0.41) | TSPOKDM4EATML3MBTL1TGM2 | |
| SCHEMBL262887 | 0.92 | TSPO (0.37) | TSPOKDM4EATML3MBTL1ICMT | |
| SCHEMBL262686 | 0.92 | TSPO (0.37) | TSPOKDM4EATML3MBTL1ICMT | |
| SCHEMBL10310215 | 0.92 | KDM4E (0.43) | TSPOKDM4EATML3MBTL1TGM2 | |
| SCHEMBL14029391 | 0.92 | ATM (0.41) | TSPOKDM4EATML3MBTL1KMT2A | |
| SCHEMBL262635 | 0.92 | ATM (0.41) | TSPOKDM4EATML3MBTL1KMT2A | |
| SCHEMBL262150 | 0.90 | ABCG2 (0.35) | TSPOKDM4EATML3MBTL1ICMT | |
| SCHEMBL262149 | 0.90 | ABCG2 (0.35) | TSPOKDM4EATML3MBTL1ICMT | |
| SCHEMBL14029429 | 0.90 | JAK2 (0.41) | TSPOKDM4EATML3MBTL1KMT2A | |
| SCHEMBL21764691 | 0.90 | KDM4E (0.43) | TSPOKDM4EATML3MBTL1TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20200373488-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2020-11-26 | — | — | US | disclosed |
| US-20180083191-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2018-03-22 | — | — | US | disclosed |
| US-20180083191-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2018-03-22 | — | — | US | disclosed |
| US-9831440-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-11-28 | — | — | US | disclosed |
| US-9831440-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-11-28 | — | — | US | disclosed |
| US-20170018711-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2017-01-19 | — | — | US | disclosed |
| US-20170018711-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2017-01-19 | — | — | US | disclosed |
| US-9461248-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9461248-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-20150005509-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2015-01-01 | — | — | US | disclosed |
| US-20150005509-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | SEMICONDUCTOR ENERGY LAB (JP) | 2015-01-01 | — | — | US | disclosed |
| US-8835018-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-09-16 | — | — | US | disclosed |
| US-8835018-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-09-16 | — | — | US | disclosed |
| EP-1985613-B1 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LAB (JP) | 2013-05-15 | — | — | EP | disclosed |
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| EP-1985613-A2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268284-A1 | Anthrcene bonded to a carbazole through an aryl amine; emits blue light with high color purity; reduced power consumption | CRY1, CRY2, CYBA | TSPO 3753/4885KDM4E 2102/4885ATM 634/4885 |
| US-20170018711-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | CYP1A1, CYP1A2, XPOT | TSPO 2882/4885KDM4E 2894/4885ATM 425/4885 |
| US-20200373488-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE IN WHICH THE ANTHRACENE DERIVATIVE IS USED | CYP1A1, CYP1A2, XPOT | TSPO 2882/4885KDM4E 2894/4885ATM 425/4885 |
| US-11171292-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used | CYP1A1, CYP1A2, XPOT | TSPO 2882/4885KDM4E 2894/4885ATM 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.